Multicenter harmonization of 89Zr PET/CT performance

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 264-267

  Makris, Nikolaos E ^a   Boellaard, Ronald ^a   Visser, Eric P ^b   De Jong, Johan R ^c   Vanderlinden, Bruno ^d   Wierts, Roel ^e   Van Der Veen, Berlinda J ^f   Greuter, Henri J N M ^a   Vugts, Danielle J ^a   Van Dongen, Guus A M S ^a   Lammertsma, Adriaan A ^a   Huisman, Marc C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d JULES BORDET INSTITUTE   (Belgium)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cross calibration; Harmonization; Image quality; Multi center

Indexed keywords

RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ZIRCONIUM 89; RADIOISOTOPE; ZIRCONIUM;

ACCURACY; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FEASIBILITY STUDY; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; PET SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; 89ZR-PET; ALGORITHM; CALIBRATION; COMPUTER ASSISTED TOMOGRAPHY; CROSS CALIBRATION; HARMONIZATION; HUMAN; IMAGE PROCESSING; METHODOLOGY; MULTI-CENTER; MULTICENTER STUDY (TOPIC); MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY;

89ZR-PET; CROSS CALIBRATION; HARMONIZATION; IMAGE QUALITY; MULTI-CENTER;

ALGORITHMS; CALIBRATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTICENTER STUDIES AS TOPIC; MULTIMODAL IMAGING; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; ZIRCONIUM;

EID: 84897951380     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.130112     Document Type: Article

References (14)

1. Wu AM. Antibodies and antimatter: the resurgence of immuno-PET. J Nucl Med. 2009;50: 2-5.
2. 89Zr-labeled monoclonal antibodies. J Nucl Med. 2003;44: 1271-1281.
3. 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. J Nucl Med. 2009;50: 1828-1836.
4. 89Zrtrastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther. 2010;87: 586-592.
5. 89Zr- ibritumomab tiuxetan and PET. Eur J Nucl Med Mol Imaging. 2012;39: 512-520.
6. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging -version 1.0. Eur J Nucl Med Mol Imaging. 2010;37: 181-200.
7. Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-offlight imaging capabilities. J Nucl Med. 2007;48: 471-480.
8. Jakoby BW, Bercier Y, Conti M, Casey ME, Bendriem B, Townsend DW. Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol. 2011;56: 2375-2389.
9. Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L, Gilardi MC. Physical performance of the new hybrid PETCT Discovery-690. Med Phys. 2011;38: 5394-5411.
10. Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40: 1507-1515.
11. 18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38: 2136-2144.
12. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45: 1519-1527.
13. Benz MR, Allen-Auerbach MS, Eilber FC, et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-Tissue sarcomas. J Nucl Med. 2008;49: 1579-1584.
14. Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012;53: 1041-1047.